ZALBIN – PDUFA Date

October 4, 2010 is the PDUFA Date for the Human Genome Sciences product ZALBIN for hepititis C.  We’ve not seen anything since the company announced that it had received a Discipline Review letter from the FDA on June 6, 2010.  The FDA cited Benefit/Risk issues for the dosing regimen.  The company indicated at that time that they thought licensure was unlikely.